Genetics of host response to leishmania tropica in mice - different control of skin pathology, chemokine reaction, and invasion into spleen and liver

PLoS Neglected Tropical Diseases

Volumn 6, Issue 6, 2012, Pages

  Kobets, Tetyana ^a   Havelková, Helena ^a   Grekov, Igor ^a   Volkova, Valeriya ^a   Vojtíšková, Jarmila ^a   Slapničková, Martina ^a   Kurey, Iryna ^a   Sohrabi, Yahya ^a   Svobodová, Milena ^b   Demant, Peter ^c   Lipoldová, Marie ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GENOTYPE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS; LIVER; MALE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE LOAD; PHENOTYPE; POLYMERASE CHAIN REACTION; SKIN DEFECT; SPLEEN; SYSTEMIC DISEASE; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; SEX DIFFERENCE; SKIN; SKIN LEISHMANIASIS;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; LIVER; MALE; MICE; MICE, INBRED BALB C; PARASITE LOAD; SEX FACTORS; SKIN; SPLEEN;

EID: 84863708097     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001667     Document Type: Article

References (55)

1. Rittig MG, Bogdan C, (2000) Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16: 292-297.
2. Reiner SL, Locksley RM, (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13: 151-177.
3. McMahon-Pratt D, Alexander J, (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206-224.
4. Farrell JP, (2002) Leishmania Boston, Dordrecht, London Kluwer Academic Publishers.
5. Kobets T, Grekov I, Lipoldová M, (2012) Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 19: 1443-1474.
6. Herwaldt BL, (1999) Leishmaniasis. Lancet 354: 1191-1199.
7. Lipoldová M, Demant P, (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet 7: 294-305.
8. Jacobson RL, (2003) Leishmania tropica (Kinetoplastida: Trypanosomatidae)- a perplexing parasite. Folia Parasit 50: 241-250.
9. Svobodova M, Votypka J, Peckova J, Dvorak V, Nasereddin A, et al. (2006) Distinct transmission cycles of Leishmania tropica in 2 adjacent foci, Northern Israel. Emerg Infect Dis 12: 1860-1868.
10. Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN, (1993) Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328: 1383-1387.
11. Sacks DL, Kenney RT, Kreutzer RD, Jaffe CL, Gupta AK, et al. (1995) Indian kala-azar caused by Leishmania tropica. Lancet 345: 959-961.
12. Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, et al. (2008) Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am J Trop Med Hyg 79: 435-437.
13. Lira R, Méndez S, Carrera L, Jaffe C, Neva F, et al. (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89: 331-342.
14. Girginkardeşler N, Balcioǧlu IC, Yereli K, Özbilgin A, Özbel Y, et al. (2001) Cutaneous leishmaniasis infection in BALB/c mice using a Leishmania tropica strain isolated from Turkey. J Parasitol 87: 1177-1178.
15. Sacks D, Noben-Trauth N, (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845-858.
16. Anderson CF, Lira R, Kamhawi S, Belkaid Y, Wynn TA, et al. (2008) IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol 180: 4090-4097.
17. Demant P, Hart AAM, (1986) Recombinant congenic strains - a new tool for analysing genetic traits determined by more than one gene. Immunogenetics 24: 416-422.
18. Demant P, Lipoldová M, Svobodová M, (1996) Resistance to Leishmania major in mice. Science 274: 1392-1393.
19. Lipoldová M, Svobodová M, Krulová M, Havelková H, Badalová J, et al. (2000) Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun 1: 200-206.
20. Vladimirov V, Badalová J, Svobodová M, Havelková H, Hart AAM, et al. (2003) Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect Immun 71: 2041-2046.
21. Havelková H, Badalová J, Svobodová M, Vojtíšková J, Kurey I, et al. (2006) Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun 7: 220-233.
22. Kurey I, Kobets T, Havelková H, Slapničková M, Quan L, et al. (2009) Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics 61: 619-633.
23. Stassen AP, Groot PC, Eppig JT, Demant P, (1996) Genetic composition of the recombinant congenic strains. Mamm Genome 7: 55-58.
24. Grekov I, Svobodová M, Nohýnková E, Lipoldová M, (2011) Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium. J Microbiol Methods 87: 273-277.
25. Rogers ME, Ilg T, Nikolaev AV, Ferguson MAJ, Bates PA, (2004) Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430: 463-467.
26. Titus RG, Marchand M, Boon T, Louis JA, (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545-555.
27. Kobets T, Badalová J, Grekov I, Havelková H, Svobodová M, et al. (2010) Leishmania parasite detection and quantification using PCR-ELISA. Nat Protoc 5: 1074-1080.
28. Lipoldová M, Svobodová M, Havelková H, Krulová M, Badalová J, et al. (2002) Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 54: 174-183.
29. Howard JG, Hale C, Chan-Liew WL, (1980) Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol 2: 303-314.
30. Longley R, Smith C, Fortin A, Berghout J, McMorran B, et al. (2011) Host resistance to malaria: using mouse models to explore the host response. Mamm Genome 22: 32-42.
31. Lipoldová M, Kosařová M, Zajícová A, Holáň V, Hart AA, et al. (1995) Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics 41: 301-311.
32. Holáň V, Lipoldová M, Demant P, (1996) Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2. Immunogenetics 44: 27-35.
33. Havelková H, Badalová J, Demant P, Lipoldová M, (2000) A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA. Genes Immun 1: 483-487.
34. Lipoldová M, Havelková H, Badalová J, Demant P, (2005) Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function and lung tumor susceptibility. Int J Cancer 114: 394-399.
35. Havelková H, Holáň V, Kárník I, Lipoldová M, (2006) Mouse model for analysis of non-MHC genes that influence allogeneic response: recombinant congenic strains of OcB/Dem series that carry identical H2 locus. Cent Eur J Biol 1: 16-28.
36. Šíma M, Havelková H, Quan L, Svobodová M, Jarošíková T, et al. (2011) Genetic control of resistance to Trypanosoma brucei brucei infection in mice. PLoS Negl Trop Dis 5: e1173.
37. Shockley KR, Churchill GA, (2006) Gene expression analysis of mouse chromosome substitution strains. Mamm Genome 17: 598-614.
38. Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, et al. (2003) Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 35: 357-362.
39. Alexander J, (1988) Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology 96 (Pt 2): 297-302.
40. Mock BA, Nacy CA, (1988) Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 56: 3316-3319.
41. Giannini MS, (1986) Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice. Parasite Immunol 8: 31-37.
42. Alexander J, Irving K, Snider H, Satoskar A, (2010) Sex hormones of host responses against parasites. In: Klein SL, Roberts CW, editors. Sex hormons and immunity to infection pp. 147-186 Springer Heildelberg, Dordrecht, London, New York, 2010.
43. Sakthianandeswaren A, Curtis JM, Elso C, Kumar B, Baldwin TM, et al. (2010) Fine mapping of Leishmania major susceptibility locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun 78: 2734-2744.
44. Lee AH, Hong JH, Seo YS, (2000) Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 350 Pt 1: 131-138.
45. Allen SJ, Crown SE, Handel TM, (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787-820.
46. Teixeira JM, Teixeira CR, Andrade BB, Barral-Netto M, Barral A, (2006) Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol 22: 32-40.
47. Oghumu S, Lezama-Davila CM, Isaac-Marquez AP, Satoskar AR, (2010) Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 126: 389-396.
48. Battacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, et al. (2002) Chemokine-induced leishmanicidal activity in murine macrophages via generation of nitric oxide. J Infect Dis 185: 1704-1708.
49. Brandonisio O, Panaro MA, Fumarola L, Sisto M, Leogrande D, et al. (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1α induce nitric oxide release and enchance parasite killing in Leishmania infantum-infected macrophages. Clin Exp Med 2: 125-129.
50. Da Costa Santiago H, Ferreira Oliveira C, Santiago L, Oliveira Ferraz F, de Glória de Souza D, et al. (2004) Involvement of chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 72: 4918-4923.
51. Ritter U, Moll H, Laskay T, Brocker E, Velazco O, et al. (1996) Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 173: 699-709.
52. Johnson J, Suzuki Y, Mack D, Mui E, Estes R, et al. (2002) Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol 32: 179-185.
53. Masocha W, Amin DN, Kristensson K, Rottenberg ME, (2008) Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice. Scand J Immunol 68: 484-491.
54. Rathkolb B, Noyes HA, Brass A, Dark P, Fuchs H, et al. (2009) Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection. Infect Immun 77: 3948-3957.
55. Helegbe GK, Yanagi T, Senba M, Huy NT, Shuaibu MN, et al. (2011) Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure. Parasitol Res 108: 807-814.